Related Experiment Video
Updated: Jun 30, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.0K
Secure federated learning for Alzheimer's disease detection
Angela Mitrovska1,2, Pooyan Safari1, Kerstin Ritter2,3
1Fraunhofer-Institut fur Nachrichtentechnik, Heinrich-Hertz-Institute (HHI), Berlin, Germany.
Frontiers in Aging Neuroscience
|March 22, 2024
Summary
Federated Learning (FL) enables Alzheimer's Disease (AD) detection using brain MRI scans without sharing private patient data. This approach maintains privacy and performs comparably to centralized methods, even with diverse data.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Machine Learning (ML) shows promise for neuroimaging analysis but is hindered by data privacy concerns and the lack of large public datasets.
- Federated Learning (FL) offers a solution by enabling model training on decentralized data without compromising patient privacy.
Purpose of the Study:
- To train a Machine Learning (ML) model for Alzheimer's Disease (AD) detection using structural MRI (sMRI) data within a Federated Learning (FL) framework.
- To compare the performance of FL algorithms (Federated Averaging and Secure Aggregation) against centralized ML training.
- To investigate the impact of data heterogeneity (demographics, diagnosis, imbalance) on FL model performance for AD detection.
Main Methods:
- Implementation of two FL aggregation algorithms: Federated Averaging (FedAvg) and Secure Aggregation (SecAgg).
- Simulation of heterogeneous environments to assess the influence of demographic and diagnostic data distributions.
- Comparison of FL models with a centralized ML model trained on the same data.
- Evaluation of privacy guarantees using simulated membership inference attacks.
Main Results:
- FL models demonstrated comparable performance to centralized training for Alzheimer's Disease detection.
- Simulated heterogeneous environments revealed the impact of data distribution differences on FL model accuracy.
- Secure Aggregation (SecAgg) provided enhanced privacy protection against membership inference attacks compared to FedAvg and centralized methods.
Conclusions:
- Federated Learning (FL) is a viable and privacy-preserving approach for developing ML models for Alzheimer's Disease detection from neuroimaging data.
- Addressing data heterogeneity is crucial for robust FL model development in clinical applications.
- FL, particularly with Secure Aggregation (SecAgg), offers significant advantages in protecting patient privacy in medical AI research.
Related Concept Videos
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113

